Solid Biosciences develops gene therapy candidates for rare neuromuscular and cardiac diseases, starting with Duchenne muscular dystrophy. It last closed at $6.25 on Nov 20, down 2.95% on the day. For the quarter ended Sep 2026, SLDB reported EPS of -$0.36. Over its last 8 reports the stock moved an average of 12.4% the session after earnings. Over the last 12 months SLDB insiders bought $0 of stock on the open market and sold $2.7M, according to SEC Form 4 filings.
AI Auto Pilots
Is SLDB in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold SLDB.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on SLDBStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
SLDB · as of the Nov 20 close · updated each morning
Downtrend
The stock is 4% below its 20 day and 10% below its 50 day average. It is 23% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 45). The nearest support is the Pivot S1 at $6.12, and the nearest resistance the Pivot at $6.33.
Short trendBearish
Long trendBearish
MomentumWeak
StretchNormal
VolatilityNormal, 7.5%/day
Key levels
$11.4552 week high+83.2%
$8.08100 day average+29.3%
$7.68200 day average+22.9%
$6.8850 day average+10.1%
$6.58Swing high (Oct 21)+5.3%
$6.5020 day average+4.0%
$6.46Pivot R1+3.4%
$6.33Pivot+1.3%
$6.25Last close
$6.12Pivot S1−2.1%
$5.83Swing low (Nov 2)−6.7%
$4.4452 week low−29.0%
Indicators
RSI (14)
44.53
Middle of its range
Neutral
MACD
-0.09
Below its signal line
Bearish
Stochastic
22.9
Middle of its range
Neutral
ADX (14)
18.2
No clear trend
Williams %R
-87.0
Oversold below −80, overbought above −20
Oversold
CCI (20)
-36.7
Oversold below −100, overbought above 100
Neutral
Rate of change
−5.2%
Change over 10 sessions
Bearish
ATR (14)
$0.47
Typical daily range, 7.5% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Pullback inside a longer uptrend
Short trendBearish
Long trendBullish
MomentumWeak
StretchNormal
VolatilityNormal, 18.3%/day
Key levels
$11.4552 week high+83.2%
$8.08100 day average+29.3%
$7.68200 day average+22.9%
$6.8850 day average+10.1%
$6.58Swing high (Oct 21)+5.3%
$6.5020 day average+4.0%
$6.46Pivot R1+3.4%
$6.33Pivot+1.3%
$6.25Last close
$6.12Pivot S1−2.1%
$5.83Swing low (Nov 2)−6.7%
$4.4452 week low−29.0%
Indicators
RSI (14)
42.51
Middle of its range
Neutral
MACD
-0.40
Below its signal line
Bearish
Stochastic
23.1
Middle of its range
Neutral
ADX (14)
18.6
No clear trend
Williams %R
-83.0
Oversold below −80, overbought above −20
Oversold
CCI (20)
-86.4
Oversold below −100, overbought above 100
Neutral
Rate of change
−28.2%
Change over 10 sessions
Bearish
ATR (14)
$1.15
Typical daily range, 18.4% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Above
MA 200Above
What happened before, for SLDB
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how SLDB did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow SLDB usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for SLDBHow many large options trades hit SLDB, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in SLDB in the last 90 days.
From SEC Form 4 filings by SLDB's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether SLDB is in one of them and how their past SLDB trades turned out.
Solid Biosciences is a life sciences company based in Charlestown, Massachusetts, that develops gene therapy candidates for rare neuromuscular and cardiac diseases. Its lead candidate, SGT-003, is designed to treat Duchenne muscular dystrophy by delivering a gene that produces a smaller version of the dystrophin protein. The company is also developing candidates for Friedreich's ataxia and other genetic heart diseases. Its work is aimed at patients living with these rare conditions, many of whom have few treatment options.